|
HS Code |
446328 |
| Chemical Name | N-(Tert-Butoxycarbonyl)Sulfamide |
| Cas Number | 144570-58-7 |
| Molecular Formula | C5H12N2O3S |
| Molecular Weight | 196.23 |
| Appearance | White to off-white solid |
| Melting Point | 163-167 °C |
| Solubility | Slightly soluble in water; soluble in DMSO and methanol |
| Purity | Typically ≥98% |
| Storage Conditions | Store at 2-8°C, in a dry, sealed container |
| Synonyms | Boc-sulfamide, tert-Butyl N-sulfamoylcarbamate |
| Inchi | InChI=1S/C5H12N2O3S/c1-5(2,3)10-4(8)7-11(6,9)12/h1-3H3,(H2,6,9)(H,7,8) |
| Smiles | CC(C)(C)OC(=O)NS(=O)(=O)N |
As an accredited N-(Tert-Butoxycarbonyl)Sulfamide factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Supplied in a 25-gram amber glass bottle with a white screw cap, featuring a printed label detailing chemical name and handling precautions. |
| Shipping | N-(Tert-Butoxycarbonyl)sulfamide should be shipped in tightly sealed containers, away from moisture, heat, and incompatible materials. It must be clearly labeled as a chemical substance, with all safety datasheet (SDS) information provided. Ensure transport complies with relevant regulations, and use appropriate protective packaging to prevent leaks or spills during transit. |
| Storage | **N-(Tert-Butoxycarbonyl)Sulfamide** should be stored in a cool, dry, and well-ventilated area, away from sources of ignition, heat, and incompatible substances like strong acids or oxidizers. Keep the container tightly closed and protected from moisture. Store at room temperature or as specified by the manufacturer, and ensure proper labeling to avoid accidental misuse or contamination. |
Applications of N-(Tert-Butoxycarbonyl)Sulfamide in Industrial ManufacturingAs a direct manufacturer, we supply N-(Tert-Butoxycarbonyl)Sulfamide for several industrial sectors where specialty intermediates are essential. Our product meets the needs of regulated downstream environments in the pharmaceutical, fine chemical, agrochemical, and specialty reagent fields. Below, we detail its established roles across diverse production chains. 1. Active Pharmaceutical Ingredient (API) Intermediate SynthesisPharmaceutical companies incorporate N-(Tert-Butoxycarbonyl)Sulfamide as a protected sulfamide synthon during multi-step API intermediate synthesis, particularly in heterocyclic molecule construction. Its tert-butoxycarbonyl (Boc) group provides strategic amine protection compatible with hydrogenation and coupling reactions, while the sulfamide functionality supports selective incorporation in antihypertensive, antineoplastic, and antiviral API frameworks. Controlled deprotection schedules enable process streamlining and yield consistency in regulated manufacturing settings. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Peptide and Peptidomimetic SynthesisManufacturers of research peptides and peptide-like drugs leverage this compound as a transient amine-protecting and functionalizing agent. Its Boc-protected sulfamide moiety allows selective incorporation into the peptide backbone, granting access to sterically encumbered or electron-deficient amide bonds while maintaining orthogonality in multi-step solid and solution-phase peptide synthesis protocols. Strategic placement in sequence design facilitates introduction of sulfamide linkages, which are critical for medicinally relevant peptidomimetics. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Agrochemical Synthesis for Sulfonylurea HerbicidesIn agrochemical manufacturing, N-(Tert-Butoxycarbonyl)Sulfamide serves as a key intermediate for the controlled synthesis of herbicidal sulfonylureas. Its use enables the stepwise introduction of protected sulfamide groups, which participate in condensation with isocyanates and aryl halides to form potent herbicide scaffolds. The Boc group allows selective deprotection, minimizing side-reactions and maximizing target compound purity in batch or continuous production systems. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Specialty Chemical Reagent ManufacturingProducers in the specialty reagent sector utilize this protected sulfamide as a building block for the synthesis of bifunctional linkers, sulfonamide connectors, and custom analytical derivatization agents. The compound’s structure permits precise timing of Boc deprotection during post-modification or cross-coupling operations, supporting chemoselective processes in analytical chemistry and molecular probe development. High purity and traceability requirements are maintained to suit analytical and diagnostic environments. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
5. Fine Chemical Intermediates in Heterocyclic Compound SynthesisProducers of heterocyclic fine chemicals implement this compound as a selective source of protected sulfamide for constructing pyrazole, triazole, and other nitrogen-rich ring systems. Its reactivity supports stepwise condensation, cyclization, or ring-closure strategies by mitigating unwanted side reactions. Careful control of protection/deprotection aligns with batch or continuous production, aiming for high yields and minimized impurities in advanced intermediate synthesis. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive N-(Tert-Butoxycarbonyl)Sulfamide prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Pulling from years spent on the production line and in the pilot reactor, I have watched a wave of new reagents enter the sulfonamide market. Out of these, N-(Tert-Butoxycarbonyl)Sulfamide, which many industry chemists know as Boc-sulfamide, draws the attention of formulators and process chemists who require reliability under precise conditions. Our version, made under controlled anhydrous environments with close monitoring at each stage, owes its performance to hands-on oversight and persistent in-house process improvement.
Reactions often favor the specific reactivity profile that Boc-sulfamide offers. Chemists searching for gentle protection alongside reliable downstream transformations pivot to this molecule for its protective Boc group. Our technical teams have measured purity consistently above 98%, and quality control checks ensure the physical form remains a white crystalline powder, free from coloring that might indicate impurity carryover. The careful packaging—kept away from moisture and sunlight—protects against clumping and decomposition, setting a high bar compared to off-spec or mishandled imports encountered too often in the field.
For scale-up or repeat batch work, reproducibility beats any other concern. Sulfamide core structures stand at the root of multiple pharmaceutical and agrochemical routes. In our experience, impurities—sometimes as little as a percent or two—lead to yield loss or by-products that defy easy separation. Boc-sulfamide pure lots display stable melting points in tight ranges, and routine HPLC checks often show single-main peaks, an indicator of the control exerted during its synthesis.
Seasoned users understand that contaminants, residual solvents, or incorrect water content cause headaches downstream. Sometimes, lower-cost alternatives seem attractive, but the hidden costs show up in crystallization failures or sticky residues. Over time, companies learn that an extra degree of confidence in feedstock matches cost savings. Our own clients, from API developers to materials science labs, have reported reduced purification steps and fewer deviations after switching from variable sources.
Fielding technical questions about substituent effects, our teams bring up laboratory data and practical knowledge. Standard sulfamides and substituted variants differ significantly in how they handle nucleophilic attack or oxidative stress. The tert-butoxycarbonyl group on this molecule serves two jobs: it shields the nitrogen, preventing unwanted reactions, and it also opens up deprotection pathways under mild conditions. Simple sulfamides without this group participate too easily, especially when exposed to electrophiles or bases, which limits selective transformations.
The Boc-protected format withstands standard storage and resists hydrolysis much better than unprotected alternatives. Some labs experiment with benzyloxycarbonyl or acetyl groups as temporary protection, but they struggle with either incomplete removal or insufficient stability. Chemists running parallel syntheses come back to tert-butoxycarbonyl for the clean deprotection and broad compatibility.
From firsthand observations during trials, Boc-sulfamide enables high-yield coupling with aryl or alkyl halides using both classical and modern palladium catalysis. Test reactions on model systems show that the protective group holds up even when exposed to moderately elevated temperatures, reducing instances of premature sulfamide cleavage. As a manufacturer, consistent batch quality shifts downstream troubleshooting back toward substrate challenges instead of reagent inconsistencies.
Several pharmaceutical developers relay that scale-up work with our sulfamide cuts back on labor wasted during unwanted side-product removal. Instead of running extra columns or extending workups with dubious results, labs lean on proven reagent quality. Feedback loops from regular clients guide our continuous improvement efforts, narrowing lots that display minor variances while ramping up uniform results.
Request sheets reflect broadening usage in pharmaceutical intermediates, peptidomimetics, and modern ligand design. In targeted drug synthesis, where every yield point and step cost counts, Boc-sulfamide appears on the bring list for key intermediates. Agrochemical projects run recurring tests with it, using the selective protection to build key motifs on sensitive substrates.
A growing trend involves incorporating sulfamide-based linkers into enzyme inhibitors and prodrug structures. Because Boc protection endures pH swings and selective reductions, researchers gain a versatile handle for late-stage manipulations. The chemistry expands into material modification routines, where the molecule’s dual functionality gets leveraged for custom polymer or cross-linker development.
We have found that every kilogram of product owes its reliability not just to machine calibration but to relentless day-to-day stewardship. Some companies rely on broad specification limits, focusing on volume. Our team leans heavily on process analytics and keeps an open communication channel between production, quality, and safety teams. It is not uncommon for production operators to halt the line and rerun a purification based on visual inspection, even if the numbers still fall within average range. That oversight translates into more predictable crystallinity and shelf-stable stock.
Training plays a real part here. New operators go through a period shadowing our senior staff, learning nuanced points that no SOP or checklist captures. Over the years, regular in-process audits pinpointed causes for marginal off-colors or shifts in melting range, spurring investments in improved filtration and agitation systems. Attention to detail brings about lots that pour more freely, with less tendency to cake, which frequent users immediately notice compared to bulk alternatives.
Production of Boc-sulfamide tends to generate less problematic waste streams than other protection strategies involving heavier metals or halogenated reagents. Our engineering team, after internal review and small-scale test runs, swapped older chlorinated solvents out for greener options, lowering operator exposure risks and reducing regulatory compliance costs. Filtration media, previously a source of micro-particle contamination, transitioned to higher-purity forms after customer feedback highlighted an issue during scale-up purification.
Being the source manufacturer, not a middleman, means every process tweak has an immediate effect on both output quality and waste footprint. Process chemists and EHS teams work side by side, tracing failure points not with the aim of assignment but for system improvement. We patrol not only certificates of analysis but also batch histories and trend files, ensuring outlier batches do not pass quietly into distribution.
The market sometimes experiences shortages of Boc reagents due to supplier disruptions or spot price shifts on essential feedstocks. We source precursor chemicals only after vetting continuity and verifying documentation for purity and chain of custody. Demand surges—from new drug development or regulatory shifts—do not faze or upend our deliveries, thanks to forward-planned inventories supported by local warehousing.
Direct control over every production stage supports rapid traceability. When clients in pharmaceutical QA request back tracing, our logs and physical plant tracking can pull up every step from raw input to finished grade. Spec documentation, rather than a post-market addition, is generated during live production and updated as needed to reflect in-process results, not estimated outcomes.
Several partners, academic and industrial, have sent us protocol feedback showing how minor lot-to-lot differences in competitor samples disrupt synthetic reproducibility. Collaborating directly, our technical teams analyzed shared NMR and LC-MS results to troubleshoot artifact peaks and ghost impurities. On-site sample reanalysis discovered cyclic contaminants that escaped routine checks at labs buying from less transparent sources.
These cases led to equipment upgrades and new analyst training on subtle contamination flags. A shift from old titration checks to modern instrument-assisted quantification precisely caught moisture inclusions, prompting improvements to the drying room protocol. Such direct partnerships result in fewer blind spots and a more predictable research experience for customers in discovery chemistry settings.
Our team understands the persistent challenges with Boc group installation and the subsequent purification of sulfamides. Fluctuating humidity, batch-to-batch differences in di-tert-butyl dicarbonate (Boc2O) purity, and the need for clean, fast filtration all factor into outcome quality. Over time, process analytics and focused operator skills have driven down impurity carryovers and increased yield predictability per run.
Downstream, our own R&D group runs monthly synthetic checks on each finished batch, testing coupling potential and resistance to typical acidic or basic workups. We do not rely on external validation alone, using in-house NMR and elemental analysis to maintain a tight feedback loop between QA and production. Feedback from experienced bench chemists in the pharmaceutical sector aligns closely with our findings—robust, clean, easily handled sulfamide intermediates save time all the way through submission of regulatory documentation.
Veteran synthetic chemists point to shorter reaction times, fewer purification steps, and improved mass balance when using pure Boc-sulfamide from a source that reports every significant test. The strong physical properties, namely controlled particle size and freedom from sticky or lumping tendencies, let automation specialists tackle larger scales with little intervention. In peptide and unnatural amino acid research, predictable solubility and batch response reduce surprises during critical coupling or deprotection steps.
Clients moving away from basic unprotected sulfamides notice reduced failure rates under typical coupling conditions with acid chlorides and isocyanates due to the molecule’s sterically protected nitrogen. Instead of unwanted urea or disulfide by-products, downstream isolations recover more of the intended intermediate, shifting project timelines forward. Crucially, research groups fed up with inconsistent materials, often from far-off traders or complex middlemen, have reported fewer failed projects and more predictable time to milestone after switching to a carefully sourced manufacturer.
Protection with tert-butoxycarbonyl enables more aggressive intermediate transformations without risking loss of the sulfamide moiety. In pilot-scale vaccine adjuvant development, Boc-sulfamide helps chemists maintain reactive handles until the right stage for deprotection. Experience shows that common acids like trifluoroacetic acid or HCl in dioxane strip the group reliably, minimizing side reactions or harsh conditions that threaten final product structure.
Technicians appreciate the predictable response of Boc-sulfamide to both acidic and basic environments, which broadens the operational window for less experienced chemists and apprentices. Training sessions for new hires include hands-on work with the material, driving home the importance of careful work-up and precise stoichiometry. The need for less re-processing or column reruns shows up clearly in manufacturing throughput statistics over time.
Shipping Boc-sulfamide requires vigilance, especially for larger orders crossing climate zones. Experience highlighted the risk of trace hydrolysis and caking during transport, prompting investments in barrier-seal packaging and climate-controlled warehousing. Bulk shipments go out in tamper-evident drums with humidity indicators that verify the chain of storage conditions, meeting the requirements of leading labs for material traceability and reliability.
On receipt, our material resists yellowing or clumping under typical ambient storage. Regular customers have flagged lot changes that tie back to subtle shipping damage or exposure to high humidity—feedback which led us to insist on reinforced packaging even on seemingly routine shipments. The careful approach pays off with higher assay values and preserved product over extended storage periods.
R&D partnerships, both long and short term, have brought emerging needs from active pharmaceutical ingredient research and advanced material design straight to our technical teams. Formula tweaks made after joint troubleshooting with industry users led to refinements in drying stages and additional low-end size cuts, ensuring that even sensitive automation runs receive a free-flowing product that eliminates downtime caused by bridging or feeder blockage.
Listening to on-the-ground chemists, especially during visits at production sites, gives our staff direct insight into daily pain points. Adjustments made at our end brought rates of failed automated dispensing down, and the resulting process documentation now serves as a troubleshooting guide for newer users. The two-way dialogue extends from plant floor to research bench, shaping ongoing product design in the spirit of practical collaboration.
For regulated environments—GMP API projects, pilot pharmaceutical development, or advanced agrochemical work—document control, full traceability, and consistent performance receive as much emphasis as the baseline physical chemistry tests. Internal process planning keeps all documentation current and aligns data capture strategies with evolving international requirements. Frequent audits by both internal and external parties drive improvement and help preempt questions from regulatory reviewers.
We routinely supply detailed batch records on request, accompanied by signed certificates for each lot. Reanalysis is performed before shipment for lots intended for regulatory submission. Over years in the field, these practices have reduced back-and-forth inquiries from clients prepping for submission or post-market quality reviews. By understanding both the technical and compliance needs, our teams support clients’ projects without last-minute panic stock-outs or documentation gaps.
Drug development programs and agricultural research both cycle through phases of rapid expansion and sudden shifts in desired intermediates. With flexible reaction setups and a network of established raw material sources, we increase output within controlled windows, keeping rush orders on schedule without compromising the batch records or QC logs.
For scale-up phases, real-time lab data pipelines guide immediate production adjustment and rapid estimation of deliverable timelines. Consultations with senior staff at client companies allow tuning of technical parameters or packaging options. Our commitment extends beyond one-off orders, focusing instead on building relationships that support whole project cycles, from concept through scale-up to campaign production.
Batch retrospectives handled by our senior operators have turned up several learning experiences still used in training today—a sudden impurity spike after a raw input change, or a small but reproducible shift in crystal habit traced to a change in anti-solvent temperature. Relearning lessons already known by more experienced producers helps cement a culture of humility and vigilance in each subsequent run.
Continuous improvement is not merely a slogan but a routine reality here, supported by cross-functional review and the explicit linkage of customer feedback to process workflow. Over time, this habit of close listening and process retracing translates directly into more robust, longer-shelf-life products and fewer field complaints.
Direct manufacturing experience forms the bedrock for every quality claim and performance metric. Knowing the upstream chemistry, monitoring every input, and owning the output’s destiny fosters materials that support predictable, high-yield chemistries. Boc-sulfamide, when prepared with care, serves not simply as a commodity but as a backbone of advanced synthesis—trusted by both those at the bench and at the planning table.